Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer
Daniela Noa Zohar, Yehuda Shoenfeld Zabludowitz Centre for Autoimmune Diseases, Sheba Medical Centre, Tel-Hashomer, IsraelBelzile et al introduce a novel therapeutic approach for cancer by antibody targeting of phosphatidylserine (PS).1 As is well known, antiphospholipid...
Main Authors: | Zohar DN, Shoenfeld Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/aantibody-targeting-of-phosphatidylserine-for-the-detection-and-i-peer-reviewed-article-ITT |
Similar Items
-
Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
by: Massimo Radin, et al.
Published: (2020-12-01) -
Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01) -
Hallux Partial Necrosis Associated with Antiphospholipid Syndrome: The Importance of Early Accurate Diagnosis
by: Antonio Córdoba-Fernández, et al.
Published: (2023-04-01) -
Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort
by: Michael T Mullen, et al.
Published: (2012-09-01) -
Anticorpos antifosfolípides em 66 pacientes com infarto cerebral entre 15 e 40 anos Antiphospholipid antibodies in 66 patients with cerebral infarction between 15 and 40 years old
by: José Ibiapina Siqueira Neto, et al.
Published: (1996-12-01)